Strongyloides infection screening in transplant candidates: What is the best strategy?
Transplant Infectious Disease · 2023
DOI: 10.1111/tid.14153 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transplant Infectious Disease, 2023. Verfasst von Ronaldo Cesar Borges Gryschek und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratório de Investigação Médica (LIM/06), Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Sao Paulo, Brazil. Hauptthemen laut MEDLINE: Strongyloidiasis, Strongyloides stercoralis. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: Fundação de Amparo à Pesquisa do EStado de São Paulo (FAPESP).
Abstract (Originalsprache)
Background
The potential that Strongyloides stercoralis infection has to cause major morbidity and high mortality when the disseminated form occurs in transplant patients is of particular concern.
Methods
In this study, the objective was to observe S. stercoralis infection in patients who are candidates for transplantation by using parasitological, serological, and molecular techniques and to propose an algorithm for the detection of that infection in transplant candidates.
Results
By parasitological techniques, 10% of fecal samples were positive. Anti‐ Strongyloides antibodies immunoglobulin G were detected in 19.3% and 20.7% of patients by immunofluorescence assay and enzyme‐linked immunosorbent assay, respectively. S. stercoralis DNA was observed in 17.3% of samples by conventional polymerase chain reaction and 32.7% of samples by quantitative polymerase chain reaction (qPCR).
Conclusion
The set of results allows us to reinforce that a positive result by parasitological techniques and/or qPCR indicates that the specific treatment should be applied. However, the improvement of diagnostic techniques may suggest changes in the screening for strongyloidiasis in these patients. image
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratório de Investigação Médica (LIM/06), Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Sao Paulo, Brazil.
- Immunosuppressed Infection Group, Divisão de Moléstias Infecciosas e Parasitárias do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Sao Paulo, Brazil.
- Faculdade de Ciências Médicas da Santa Casa de Misericórdia de São Paulo, Sao Paulo, Brazil.
ORCID-Profile: Ronaldo Cesar Borges Gryschek, Ligia Camera Pierrotti, Fabiana Martins de Paula
Förderung
- Fundação de Amparo à Pesquisa do EStado de São Paulo (FAPESP)
Zitieren
APA
Gryschek, R. C. B., Corral, M. A., Sitta, R. B., Gottardi, M., Pierrotti, L. C., Costa, S. F., Abdala, E., Chieffi, P. P., & de Paula, F. M. (2023). Strongyloides infection screening in transplant candidates: What is the best strategy?. Transplant Infectious Disease. https://doi.org/10.1111/tid.14153
Vancouver
Gryschek RCB, Corral MA, Sitta RB, Gottardi M, Pierrotti LC, Costa SF, et al. Strongyloides infection screening in transplant candidates: What is the best strategy?. Transplant Infectious Disease. 2023. doi:10.1111/tid.14153
BibTeX
@article{Gryschek2023,
author = {Gryschek, Ronaldo Cesar Borges and Corral, Marcelo Andreetta and Sitta, Renata Barnabé and Gottardi, Maiara and Pierrotti, Ligia Camera and Costa, Silvia Figueiredo and Abdala, Edson and Chieffi, Pedro Paulo and de Paula, Fabiana Martins},
title = {Strongyloides infection screening in transplant candidates: What is the best strategy?},
journal = {Transplant Infectious Disease},
year = {2023},
doi = {10.1111/tid.14153}
}
EUVIMED